Skip to main content
Ananda Pharma Plc (AQU:ANA)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.2750
0.00 (0.00%)
At close: Aug 13, 2025

Ananda Pharma Cash Flow Statement

Millions GBP. Fiscal year is Feb - Jan.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2019 - 2020
Period Ending
 Jan '25 Jan '24 Jan '23 Jan '22 Jan '21 2019 - 2020
Net Income
-3.77-6.15-1.3--
Upgrade
Depreciation & Amortization
0.223.420.17--
Upgrade
Asset Writedown & Restructuring Costs
0.411.690.04--
Upgrade
Stock-Based Compensation
1.150.020.01--
Upgrade
Other Operating Activities
0.35-0.790.42--
Upgrade
Change in Accounts Receivable
-0.080.14-0.14--
Upgrade
Change in Accounts Payable
0.890.950.34--
Upgrade
Operating Cash Flow
-0.82-0.72-0.46--
Upgrade
Capital Expenditures
--0---
Upgrade
Cash Acquisitions
-0.020.03--
Upgrade
Investment in Securities
---1.48--
Upgrade
Other Investing Activities
0.020---
Upgrade
Investing Cash Flow
0.020.02-1.45--
Upgrade
Long-Term Debt Issued
-0.31.89--
Upgrade
Long-Term Debt Repaid
---0.04--
Upgrade
Net Debt Issued (Repaid)
-0.31.85--
Upgrade
Issuance of Common Stock
2.380.470.07--
Upgrade
Financing Cash Flow
2.380.771.92--
Upgrade
Net Cash Flow
1.580.070.02--
Upgrade
Free Cash Flow
-0.82-0.72-0.46--
Upgrade
Free Cash Flow Margin
-1316750.00%----
Upgrade
Free Cash Flow Per Share
---0.00--
Upgrade
Levered Free Cash Flow
-0.911.92-0.41--
Upgrade
Unlevered Free Cash Flow
-0.772.01-0.25--
Upgrade
Change in Working Capital
0.821.090.2--
Upgrade
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.